Pro-DexFRA:PDXN +8.82%63 Gross Margin % is 30.74% as of Mar. 2026, which is 4% below its 10-year median of 32.00. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €36.25 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Pro-Dex ranks worse than 83.73% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Pro-Dex's Gross Profit for the
three
months ended in Mar. 2026 was €5.31 Mil. Pro-Dex's Revenue for the
three
months ended in Mar. 2026 was €17.26 Mil. Therefore, Pro-Dex's Gross Margin % for the quarter that ended in Mar. 2026 was 30.74%.
Warning Sign:
Pro-Dex Inc gross margin has been in long-term decline. The average rate of decline per year is -6.2%.
The historical rank and industry rank for Pro-Dex's Gross Margin % or its related term are showing as below:
FRA:PDXN'
s Gross Margin % Range Over the Past 10 Years
Min: 25.63 Med: 32 Max: 37.73
Current: 27.78
During the past 13 years, the highestGross Margin % of Pro-Dex was 37.73%. The lowest was 25.63%. And the median was 32.00%.
FRA:PDXN's Gross Margin % is ranked worse than 83.73% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:PDXN: 27.78
Pro-Dex had a gross margin of 30.74% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Pro-Dex was -6.20% per year.
Pro-Dex (FRA:PDXN) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Pro-Dex had a gross margin of 30.74% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Pro-Dex Gross Margin % Related Terms
Pro-Dex Gross Margin % Historical Data
* Premium members only.
The historical data trend for Pro-Dex's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDXN vs KRMD, EMBC, SMTI: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Pro-Dex's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Pro-Dex (FRA:PDXN) has a Gross Margin % of 30.74% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Pro-Dex and its competitors. This is near median its historical median of 32.00. Over the past decade, Pro-Dex's Gross Margin % has ranged from 25.63 to 37.73. According to the industry distribution chart, Pro-Dex ranks #674 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 83.7%.
Is Pro-Dex's Gross Margin % too high?
Pro-Dex's current Gross Margin % of 30.74% is near median its 10-year median of 32.00. Over the past 10 years, this metric has ranged from a low of 25.63 to a high of 37.73. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Pro-Dex's value of 30.74% is 41% below this industry median. Based on the distribution chart, Pro-Dex ranks #674 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Pro-Dex has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Gross Margin % compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #674 out of 805 companies for Gross Margin %. This places Pro-Dex in the lower half of its industry. The industry median Gross Margin % is 52.07. Pro-Dex's value of 30.74% is 41% below this benchmark. Historically, Pro-Dex's own Gross Margin % has ranged from 25.63 to 37.73 over the past decade. While the company's 10-year median is 32.00 vs. the industry median of 52.07, Pro-Dex has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro-Dex's current Gross Margin % of 30.74% is 41% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current Gross Margin % is 30.74%, which is near median its own 10-year median of 32.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €36.25, compared to a current price of €55.50 — trading 53.1% above its estimated fair value. The current Gross Margin % is 30.74%, which is near median its 10-year median of 32.00 and 41% below the Medical Devices & Instruments industry median of 52.07. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Gross Margin % is 30.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €55.50 is trading 53.1% above its estimated GF Value™ of €36.25.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
Gross Margin %: 30.74% (near median its 10-year median of 32.00)
GF Value™: €36.25 vs. price of €55.50 (53.1% above fair value)
Industry Position: 41% below the Medical Devices & Instruments median (#674 of 805)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score
Get the complete analysis for FRA:PDXN
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
